Pierre Démolis

1.2k total citations
34 papers, 677 citations indexed

About

Pierre Démolis is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Pierre Démolis has authored 34 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Economics and Econometrics. Recurrent topics in Pierre Démolis's work include Blood Pressure and Hypertension Studies (6 papers), Cerebrovascular and Carotid Artery Diseases (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Pierre Démolis is often cited by papers focused on Blood Pressure and Hypertension Studies (6 papers), Cerebrovascular and Carotid Artery Diseases (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Pierre Démolis collaborates with scholars based in France, Netherlands and Sweden. Pierre Démolis's co-authors include Jean‐François Giudicelli, Tomas Salmonson, Francesco Pignatti, Yves R. Tran Dinh, Stephan Chalon, Alexandre Moreau, Philippe Chanson, Joseph Emmerich, Manuel Haas and G Schaison and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Stroke and CHEST Journal.

In The Last Decade

Pierre Démolis

31 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Démolis France 16 151 115 108 100 82 34 677
Changfeng Man China 15 100 0.7× 195 1.7× 79 0.7× 96 1.0× 115 1.4× 45 801
Fabien Despas France 21 480 3.2× 227 2.0× 215 2.0× 124 1.2× 62 0.8× 103 1.4k
Roberta Littleford United Kingdom 14 217 1.4× 120 1.0× 95 0.9× 82 0.8× 35 0.4× 39 632
F. H. Epstein United States 10 274 1.8× 143 1.2× 158 1.5× 240 2.4× 60 0.7× 23 779
Carsten Henneges Germany 20 73 0.5× 189 1.6× 195 1.8× 153 1.5× 44 0.5× 54 1.3k
Qing Wan China 17 193 1.3× 228 2.0× 48 0.4× 79 0.8× 135 1.6× 56 848
Thomas W. Weiss Austria 22 649 4.3× 162 1.4× 74 0.7× 236 2.4× 199 2.4× 64 1.4k
A. Evans United Kingdom 13 94 0.6× 171 1.5× 44 0.4× 105 1.1× 102 1.2× 21 728
Chin-Chou Huang Taiwan 18 305 2.0× 160 1.4× 146 1.4× 97 1.0× 103 1.3× 42 1.1k

Countries citing papers authored by Pierre Démolis

Since Specialization
Citations

This map shows the geographic impact of Pierre Démolis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Démolis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Démolis more than expected).

Fields of papers citing papers by Pierre Démolis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Démolis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Démolis. The network helps show where Pierre Démolis may publish in the future.

Co-authorship network of co-authors of Pierre Démolis

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Démolis. A scholar is included among the top collaborators of Pierre Démolis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Démolis. Pierre Démolis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gravanis, Iordanis, et al.. (2025). Challenges and ongoing initiatives towards better integrated EU scientific advice. Frontiers in Medicine. 12. 1473346–1473346. 1 indexed citations
2.
Bowen, Debra L., Jorge Camarero, Pierre Démolis, et al.. (2015). Early market access of cancer drugs in the EU. Annals of Oncology. 27(1). 96–105. 61 indexed citations
3.
4.
Trivalle, C., et al.. (2010). Identifying and preventing adverse drug events in elderly hospitalised patients: A randomised trial of a program to reduce adverse drug effects. The journal of nutrition health & aging. 14(1). 57–61. 46 indexed citations
5.
Chanson, Philippe, Jean‐Marc Kuhn, G. Weryha, et al.. (2010). Comparative Validation of the Growth Hormone-Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency Using a Growth Hormone Assay Conforming to Recent International Recommendations. The Journal of Clinical Endocrinology & Metabolism. 95(8). 3684–3692. 19 indexed citations
6.
Meurin, Philippe, Hélène Weber, Nathalie Renaud, et al.. (2004). Evolution of the Postoperative Pericardial Effusion After Day 15: The Problem of the Late Tamponade. CHEST Journal. 125(6). 2182–2187. 56 indexed citations
7.
Aymard, Guy, Dominique Warot, Pierre Démolis, et al.. (2003). Comparative Pharmacokinetics and Pharmacodynamics of Intravenous and Oral Nefopam in Healthy Volunteers*. Pharmacology & Toxicology. 92(6). 279–286. 40 indexed citations
8.
Aymard, Guy, D. Warot, Pierre Démolis, Isabelle Laville, & B. Diquet. (2002). Sensitive determination of nefopam and its metabolite desmethyl-nefopam in human biological fluids by HPLC. Journal of Pharmaceutical and Biomedical Analysis. 30(4). 1013–1021. 15 indexed citations
9.
Maison, Patrick, Pierre Démolis, Jacques Young, et al.. (2000). Vascular reactivity in acromegalic patients: preliminary evidence for regional endothelial dysfunction and increased sympathetic vasoconstriction. Clinical Endocrinology. 53(4). 445–451. 57 indexed citations
10.
Démolis, Pierre, et al.. (2000). Is the Acetazolamide Test Valid for Quantitative Assessment of Maximal Cerebral Autoregulatory Vasodilation?. Stroke. 31(2). 508–515. 24 indexed citations
11.
Démolis, Pierre. (1999). Pharmacologie des inhibiteurs de l’enzyme de conversion. 4(10). 767–774.
12.
Gervais, Marianne, et al.. (1999). Systemic and Regional Hemodynamics Assessment in Rats with Fluorescent Microspheres. Journal of Cardiovascular Pharmacology. 33(3). 425–432. 30 indexed citations
13.
Maison, Patrick, et al.. (1996). Repeatability of laser Doppler measurements of cutaneous blood flow in clinical pharmacology studies. Fundamental and Clinical Pharmacology. 10(3). 319–320. 1 indexed citations
14.
Chemla, D. S., et al.. (1996). Blood flow acceleration in the carotid and brachial arteries of healthy volunteers: respective contributions of cardiac performance and local resistance. Fundamental and Clinical Pharmacology. 10(4). 393–399. 13 indexed citations
15.
Démolis, Pierre, Stephan Chalon, & Jean‐François Giudicelli. (1995). Acetazolamide-Induced Vasodilation in the Carotid Vascular Bed in Healthy Volunteers. Journal of Cardiovascular Pharmacology. 26(5). 841–844. 9 indexed citations
16.
Démolis, Pierre, et al.. (1994). Systemic, regional and cerebral hemodynamic effects of a new angiotensin converting enzyme inhibitor, imidapril, in healthy volunteers. Fundamental and Clinical Pharmacology. 8(1). 80–89. 8 indexed citations
17.
Démolis, Pierre, Claudine Carville, & Jean‐François Giudicelli. (1993). Effects of an Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Cerebral Blood Flow Autoregulation in Healthy Volunteers. Journal of Cardiovascular Pharmacology. 22(3). 373–380. 19 indexed citations
18.
Démolis, Pierre, et al.. (1992). Effects of an angiotensin converting enzyme inhibitor, ramipril, on intracranial circulation in healthy volunteers. off. British Journal of Clinical Pharmacology. 34(3). 224–230. 2 indexed citations
19.
Démolis, Pierre, et al.. (1991). Non‐invasive evaluation of the conduit function and the buffering function of large arteries in man. Clinical Physiology. 11(6). 553–564. 28 indexed citations
20.
Asmar, Roland, et al.. (1991). [Validation of Oscillomat, a device for self-measurement of blood pressure. Comparison with mercury sphygmomanometers].. PubMed. 20(12). 551–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Changfeng Man Breakdown of academic impact, for papers by Fabien Despas Breakdown of academic impact, for papers by Roberta Littleford Breakdown of academic impact, for papers by F. H. Epstein Breakdown of academic impact, for papers by Carsten Henneges Breakdown of academic impact, for papers by Qing Wan Breakdown of academic impact, for papers by Thomas W. Weiss Breakdown of academic impact, for papers by A. Evans Breakdown of academic impact, for papers by Chin-Chou Huang
Rankless by CCL
2026